Michele Vigolo
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 11, 2024
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.
Journal: Cancer research communications
Published: August 03, 2023
Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
Journal: Cell reports
Published: March 31, 2021
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.
Journal: Cancer research
Published: February 16, 2021
Methods for the Administration of EDAR Pathway Modulators in Mice.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 13, 2020
Pharmacological disruption of the Notch transcription factor complex.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 01, 2020
No interactions between heparin and atacicept, an antagonist of B cell survival cytokines.
Journal: British journal of pharmacology
Published: November 09, 2018
Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab.
Journal: Frontiers in immunology
Published: May 01, 2018
Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia.
Journal: The New England journal of medicine
Published: April 26, 2018
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.
Journal: Nature communications
Published: October 09, 2017
Last Updated: 09/26/2026